NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/23/2024
Back to search
Official data from USPTO
SYNVANTAGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYNVANTAGE
ST13
US500000090100048Class
1, 5, 42, 44
Filing
90100048
Registration
7452470
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
64
Latest update
07/23/2024
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
08/07/2020
Registration date
07/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2024
Last transaction
07/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Karnataka, IN
Examiner
SNYDER, NELSON B
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Syngene International Limited
Representatives
Mark A. Watkins VORYS, SATRER, SEYMOUR AND PEASE LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratoryresearchclinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientificlaboratory or medical research; Reagents for scientific and research use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; Protein for industrial use; Proteins for use in manufacture; specialty chemicalschemical additives for general industrial use in the manufacture of a wide variety of goods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; Nucleic acid sequencesother than for medical or veterinary purposes; Reagents for scientific purposes for use in nucleic acid isolation and purification; gelsreagentschemical standardsdyes and trace dyes for electrophoresisother than for medical or veterinary purposes; preparative electrophoresis reagentsother than for medical or veterinary purposes
Class 5
Autonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposesfor treating diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Dietary supplements for humans and animals; Biological tissue cultures for medical purposes; Biological preparations for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Pharmaceutical preparations for the treatment of infectious diseases; Bio-logical and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof for pharmaceutical and medical usepharmaceutical preparations for the treatment of diseases and conditions in the fields of oncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; synthetic peptides for pharmaceutical purposes and for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medicalveterinary or pharmaceutical purposes; Protein arrays for medical diagnosis purposes; medicines for veterinary purposes for the treatment of skin allergiesehrlichiosisear infectiondiabeteskennel coughupper respiratory tract infectioncoccidiosisbabesiosisectoparasitesendoparasites; isotopes for medical purposes; chemical preparations for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Contrast media for in vivo imaging; Contrast agents for use in molecular imaging
Class 42
Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Scientific study and research in the fields of medicinethe preventiontreatment and management of illnesshealth care delivery; medical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Conducting clinical trials for others; biological and chemical research; bacteriological research; Biological research and analysis; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; scientific study and research in the field of reproductionhusbandrygeneral health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodiesantibody technologyimmunopharmaceuticals and vaccines; designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; toxicology services; toxicity testing for research purposes; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract scientific research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and biological laboratory for research purposes; research and development and consultation related thereto in the field of antibodiesantibody technologychemistryagrochemical pharmaceuticalsbioinformaticsbiomedical devicesbiologicsbiotechnologybiotherapeuticsbiologybiochemical preparationscell lineschemoinformaticgenetics and genetic engineeringgene expression systemsin vitro researchinhalation pharmaceuticalsmolecular sciencesmicro organismsnutritionophthalmic preparationspharmacogeneticspharmacokineticspharmacologypharmaceuticalspolymerspeptide synthesisproteinsolid state characterization; scientific and technological servicesscientific researchdevelopmentanalysistestingtechnological servicesscientific researchdevelopmentanalysistestingengineeringextractionsynthesispurification and production in the field of antibodiesactive pharmaceutical ingredients (API)biomoleculescell bank characterizationchiralitychromosome aberrationclinical chemistrycloning vectorcyclotidesDNAflow cytometrygas chromatography mass spectrometrygeneimmuno-pharmaceuticalsin vitro irritationlarge moleculeliquid chromatography mass spectrometrymicrobialsmonomersnanoparticlesnatural productspeptidesproteinsRNAsupercritical fluid chromatographysmall molecules and vaccines; Laboratory servicesimaging core lab services
Class 44
Drugalcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testingmonitoring and reporting services; pathology services for medical and diagnostic purposes
Publications
History of USPTO decisions and trademark events.
64 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2024
PUBO
PUBLISHED FOR OPPOSITION
05/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2024
ATRV
ATTORNEY REVIEW COMPLETED
04/03/2024
OTHE
CASE RETURNED TO EXAMINATION
04/03/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/03/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/01/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
04/01/2024
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
03/27/2024
PILM
PETITION INQUIRY LETTER ISSUED
03/06/2024
APET
ASSIGNED TO PETITION STAFF
03/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/05/2023
EX5G
SOU EXTENSION 5 GRANTED
12/04/2023
EXT5
SOU EXTENSION 5 FILED
12/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/03/2023
EX4G
SOU EXTENSION 4 GRANTED
06/01/2023
EXT4
SOU EXTENSION 4 FILED
06/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2022
EX3G
SOU EXTENSION 3 GRANTED
11/30/2022
EXT3
SOU EXTENSION 3 FILED
11/30/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/30/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE
10/20/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/20/2022
44EP
44(e) PETITION - RECEIVED
09/30/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/30/2022
ATRV
ATTORNEY REVIEW COMPLETED
07/29/2022
DOCK
ASSIGNED TO EXAMINER
07/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/09/2022
NREV
NOTICE OF REVIVAL - E-MAILED
07/08/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
07/08/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/08/2022
APET
ASSIGNED TO PETITION STAFF
07/08/2022
EX2G
SOU EXTENSION 2 GRANTED
07/08/2022
PGEX
PETITION GRANTED - EXTENSION REQUEST FILED
07/08/2022
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
07/06/2022
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
07/05/2022
ABN6
ABANDONMENT - NO USE STATEMENT FILED
07/04/2022
APET
ASSIGNED TO PETITION STAFF
06/22/2022
EXT2
SOU EXTENSION 2 FILED
06/01/2022
44EP
44(e) PETITION - RECEIVED
05/31/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
05/31/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2021
EX1G
SOU EXTENSION 1 GRANTED
11/30/2021
EXT1
SOU EXTENSION 1 FILED
11/30/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/30/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2021
PUBO
PUBLISHED FOR OPPOSITION
04/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/10/2020
GNRT
NON-FINAL ACTION E-MAILED
11/10/2020
CNRT
NON-FINAL ACTION WRITTEN
11/10/2020
DOCK
ASSIGNED TO EXAMINER
11/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2020
NWAP
NEW APPLICATION ENTERED
08/11/2020
Continuous trademark protection
Get notified about every new filing that threatens SYNVANTAGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.